DUOX2 and adenoma: In the patient that was a heterozygous carrier, the adenoma was able to express both wild-type (hDuox2-WT) and truncated proteins (hDuox2 K530) of DUOX2. However, the antibodies used in IHC analysis could bind to both these proteins, making it impossible to determine which protein was overexpressed in the adenoma.